Monte-Carlo simulation results. (A) Cost-effectiveness acceptability curves using WTP thresholds for each strategy in untreated DLBCL. The red curve represents the percent iterations pola-R-CHP is the cost-effective strategy at each WTP threshold; the blue curve represents the percent iterations that pola-R-CHP is no longer the cost-effective strategy. (B) Monte Carlo probabilistic sensitivity analysis results in untreated DLBCL at a WTP threshold of $150 000. This figure displays the incremental cost-effectiveness scatter plot comparing pola-R-CHP and R-CHOP, showing the iterations occurring either below the WTP threshold that represent when pola-R-CHP is the cost-effective strategy and the iterations above the WTP threshold that represent when pola-R-CHP is no longer the cost-effective strategy; the oval demonstrates the 95% confidence interval. This visually represents what was found in the cost-effectiveness acceptability curve.